Rani Maharani*abc,
Muhamad Imam Muhajira,
Jelang Muhammad Dirgantaraad,
Ari Hardiantoa,
Tri Mayantiac,
Desi Harnetiac,
Nurlelasariac,
Kindi Farabiabc,
Ace Tatang Hidayatabc,
Unang Supratmanabc and
Teruna Siahaan*e
aDepartment of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Jatinangor, West Java, Indonesia. E-mail: r.maharani@unpad.ac.id
bCentral Laboratory, Universitas Padjadjaran, Jalan Raya Bandung-Sumedang KM 21, Jatinangor 45363, West Java, Indonesia
cCentre of Natural Products and Synthesis Studies, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Jalan Raya Bandung-Sumedang KM 21, Jatinangor 45363, West Java, Indonesia
dDepartment of Chemistry, Graduate School of Science, Osaka University, Toyonaka, Osaka, 560-0043, Japan
eDepartment of Pharmaceutical Chemistry, School of Pharmacy, The University of Kansas, 2095 Constant Avenue, Lawrence, Kansas 66047, USA. E-mail: siahaan@ku.edu
First published on 4th March 2024
Correction for ‘Synthesis and anticancer evaluation of [D-Ala]-nocardiotide A’ by Rani Maharani et al., RSC Adv., 2024, 14, 4097–4104, https://doi.org/10.1039/D4RA00025K.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2024 |